Clinical Trial Update: An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Exploratory Phase 4 trial evaluating the effects of trelagliptin and alogliptin on glucose variability in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)
• Trelagliptin (trelagliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2018-12-10